[go: up one dir, main page]

ES497002A0 - Procedimiento para preparar derivados de acido acetico - Google Patents

Procedimiento para preparar derivados de acido acetico

Info

Publication number
ES497002A0
ES497002A0 ES497002A ES497002A ES497002A0 ES 497002 A0 ES497002 A0 ES 497002A0 ES 497002 A ES497002 A ES 497002A ES 497002 A ES497002 A ES 497002A ES 497002 A0 ES497002 A0 ES 497002A0
Authority
ES
Spain
Prior art keywords
procedure
acetic acid
acid derivatives
preparing acetic
preparing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES497002A
Other languages
English (en)
Other versions
ES8203848A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH154579A external-priority patent/CH641810A5/de
Priority claimed from CH17480A external-priority patent/CH645378A5/de
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of ES8203848A1 publication Critical patent/ES8203848A1/es
Publication of ES497002A0 publication Critical patent/ES497002A0/es
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18One oxygen or sulfur atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38Nitrogen atoms
    • C07D231/40Acylated on said nitrogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ES497002A 1979-02-16 1980-11-20 Procedimiento para preparar derivados de acido acetico Granted ES497002A0 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH154579A CH641810A5 (en) 1979-02-16 1979-02-16 Acetamidocephalosporanic acid derivatives, process for their preparation and pharmaceutical forms which contain them
CH17480A CH645378A5 (en) 1980-01-10 1980-01-10 Acetamidocephalosporanic acid derivatives, process for their preparation and pharmaceutical forms which contain them

Publications (2)

Publication Number Publication Date
ES8203848A1 ES8203848A1 (es) 1982-04-01
ES497002A0 true ES497002A0 (es) 1982-04-01

Family

ID=25683752

Family Applications (2)

Application Number Title Priority Date Filing Date
ES488651A Expired ES8102134A1 (es) 1979-02-16 1980-02-15 Procedimiento para preparar derivados de acido acetico
ES497002A Granted ES497002A0 (es) 1979-02-16 1980-11-20 Procedimiento para preparar derivados de acido acetico

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES488651A Expired ES8102134A1 (es) 1979-02-16 1980-02-15 Procedimiento para preparar derivados de acido acetico

Country Status (19)

Country Link
US (1) US4477448A (es)
AT (1) AT374806B (es)
CA (1) CA1161032A (es)
DE (1) DE3005012A1 (es)
DK (1) DK53780A (es)
ES (2) ES8102134A1 (es)
FI (1) FI800381A7 (es)
FR (1) FR2449093A1 (es)
GB (2) GB2046734B (es)
IE (1) IE49395B1 (es)
IL (1) IL59391A (es)
IT (1) IT8047922A0 (es)
MY (1) MY8500128A (es)
NL (1) NL8000894A (es)
NZ (1) NZ192873A (es)
PH (1) PH17926A (es)
PT (1) PT70834A (es)
SE (2) SE8000982L (es)
YU (1) YU40280A (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3165922D1 (en) * 1980-03-28 1984-10-18 Biochemie Gmbh New process for the production of cephalosporin antibiotics, and novel intermediates used in such process and their production
CH648038A5 (de) * 1981-01-19 1985-02-28 Sandoz Ag 7-((carboxymethoxyimino)-1h-pyrazol-3-yl-acetyl)amino-3-desacetoxy-3-(1-methyl-1h-tetrazol-5-yl-thio)cephalosporansaeure und salze, verfahren zur herstellung und verwendung.
GB2125033B (en) * 1982-07-23 1985-08-29 Servipharm Ltd Cephalosporins
US4698338A (en) * 1986-02-19 1987-10-06 Eli Lilly And Company 7[2-(2-aminothiazol-4-yl)-2-benzyloximino]acetamido-3[4-alkyl-5-oxo-6-hydroxy-3,4-dihydro-1,2,4-triazin-3-yl]thiomethyl cephalosporins
US5688964A (en) * 1996-02-13 1997-11-18 Eastman Kodak Company Process for preparing a acylhyrazino pyrazole derivative
KR100770419B1 (ko) * 1999-09-24 2007-10-26 니혼노야쿠가부시키가이샤 살충, 살진드기제
EP1554572B1 (en) 2001-07-25 2009-10-14 Raptor Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
CN101287411B (zh) 2005-04-28 2013-03-06 普罗秋斯生物医学公司 药物信息系统及其用途
EP2063905B1 (en) 2006-09-18 2014-07-30 Raptor Pharmaceutical Inc Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates
HUE059078T2 (hu) 2009-02-20 2022-10-28 Enhanx Biopharm Inc Glutation-alapú hatóanyagszállító rendszer
KR101909711B1 (ko) 2009-05-06 2018-12-19 라보라토리 스킨 케어, 인크. 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4024137A (en) * 1971-05-14 1977-05-17 Glaxo Laboratories Limited 7β-[2-Etherified oximino-2-(phenyl- or naphthylacetamido)] cephalosporins

Also Published As

Publication number Publication date
GB8309730D0 (en) 1983-05-18
GB2117774A (en) 1983-10-19
PT70834A (en) 1980-03-01
IL59391A (en) 1983-05-15
GB2046734B (en) 1983-09-01
IE800284L (en) 1980-08-16
AT374806B (de) 1984-06-12
IL59391A0 (en) 1980-05-30
IE49395B1 (en) 1985-10-02
GB2046734A (en) 1980-11-19
GB2117774B (en) 1984-03-21
YU40280A (en) 1983-06-30
SE8500589D0 (sv) 1985-02-08
NZ192873A (en) 1984-07-31
SE8000982L (sv) 1980-08-17
IT8047922A0 (it) 1980-02-15
ES488651A0 (es) 1980-12-16
MY8500128A (en) 1985-12-31
FR2449093B1 (es) 1983-07-29
NL8000894A (nl) 1980-08-19
CA1161032A (en) 1984-01-24
DE3005012A1 (de) 1980-11-27
US4477448A (en) 1984-10-16
FI800381A7 (fi) 1981-01-01
DK53780A (da) 1980-08-17
ATA78780A (de) 1983-10-15
ES8203848A1 (es) 1982-04-01
ES8102134A1 (es) 1980-12-16
FR2449093A1 (fr) 1980-09-12
PH17926A (en) 1985-01-31

Similar Documents

Publication Publication Date Title
ES494352A0 (es) Procedimiento para preparar derivados de acidos quinolina- carboxilicos
MX158338A (es) Procedimiento para preparar derivados del acido 7-acilamino-3-vinilcefaslosporanico
MX6094E (es) Procedimiento para preparar derivados del acido 6 beta-hidroxialquil penicilanico
AR225143A1 (es) Procedimiento para preparar derivados de fenil-metil-hidantoina
AR231635A1 (es) Procedimiento para preparar acidos azabiciclicos
MX4567E (es) Procedimiento para preparar acido de-n-propilacetico
AR226854A1 (es) Procedimiento para preparar derivados de acido trans-3-(4-oxo-4h-quinazolin-3-il)-2-propenoico
MX5149E (es) Procedimiento mejorado para la preparacion de derivados de acido cicloalquilidenmetilfenilacetico
ES505207A0 (es) Procedimiento para preparar derivados de acido quinolina- carboxilico
ES488651A0 (es) Procedimiento para preparar derivados de acido acetico
AR227525A1 (es) Procedimiento para obtener derivados de acidos ciclohexancarboxilicos
AR226446A1 (es) Procedimiento para preparar derivados de acidos fenilalcanoicos
AR222304A1 (es) Procedimiento para preparar acido 4-isohexil-1-metilciclohexano-carboxilico
MX6132E (es) Procedimiento para la preparacion de derivados de ester del acido ciclopropancarboxilico
ES497800A0 (es) Procedimiento de obtencion de derivados de acido fenilaceti-co
AR225292A1 (es) Procedimiento para preparar derivados de acido 6-halogeno-alfametil carbazol-2-acetico
ES489924A0 (es) Un procedimiento para preparar derivados de acido imidazol- dicarboxilico
MX5760E (es) Procedimiento de preparacion de derivados de acido 1-naftil-acetico
ES492693A0 (es) Procedimiento para preparar derivados de acido acilaminoben-zoico
ES503834A0 (es) Procedimiento para preparar derivados de acido 2-cloro-4- trifluoromtil-5-tiazolcarbotioico
ES494479A0 (es) Procedimiento para preparar derivados del acido 7-amino-ce- falosporanico
ES491601A0 (es) Procedimiento para la preparacion de derivados de acido n-acil-amino
MX5224E (es) Procedimiento para preparar anilidas de acido ciclopropanocarboxilico
MX5929E (es) Procedimiento para preparar derivados de acido 2-(3-aril-5-isoxazolil)-benzoico
AR218294A1 (es) Procedimiento para la preparacion de derivados de acido oleanoico